ORMP Stock Price, Chart, Stats & News
Oramed Pharmaceuticals Inc. (ORMP) is a dividend-paying stock with a current dividend yield of 5.39% as of Jun 29, 2026. It pays $0.2500 per share over the trailing twelve months and distributes annually.
Dividend safety
Dividend coverage looks healthy — ORMP pays out about 29% of earnings.
ORMP chart
Fundamentals
Gross margin | -3.95% |
Operating margin | -650.55% |
Pretax margin | 2787.20% |
Net margin | 2192.60% |
Effective tax rate | 21.41% |
ROA | 44.93% |
ROE | 25.12% |
D/E | 0.00x |
Interest coverage ratio | 1.01x |
ORMP valuation
P/E | 5.40x |
P/S | 65.95x |
P/B | 0.69x |
P/CF | -10.53x |
P/FCF | -10.04x |
P/OCF | -10.53x |
PEG | 0.01x |
EV multiple | 3.03x |
About
Oramed Pharmaceuticals Inc., founded in 2002 and based in New York, New York, specializes in the development of groundbreaking pharmaceutical treatments. Their primary focus is on creating orally ingested capsules or pills for the delivery of polypeptides, particularly aimed at managing diabetes. The company's leading product, ORMD-0801, is an oral insulin capsule that has successfully completed Phase II clinical trials for patients with diabetes.
Related lists
Similar securities
Based on sector and market capitalization
